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TO THE EDITOR Neurofibromatosis type 1 (NF1), a common autosomal dominant disorder caused by mutations in the NF1 gene, is characterized by presence of neurofibromas, skin-fold freckling, café au lait macules (CALMs) and iris Lisch nodules. So far, little is known about the etiopathogenesis of NF1-related CALMs. The NF1 gene, like other tumor suppressor genes, follows the Knudson two-hit hypothesis of tumor formation, implying that, apart from the germline NF1 mutation, an additional somatic inactivation of the remaining wild-type NF1 allele is needed to initiate tumor formation (Knudson, 1971) . In general, somatic inactivation of a tumor suppressor gene can occur via three major mechanisms: loss of heterozygosity (LOH), somatic intragenic mutations, and promoter hypermethylation. One study addressed somatic NF1 inactivation in 11 CALM melanocyte cultures and found both NF1 alleles to be present (Eisenbarth et al., 1997) . However, this study only searched for LOH, and not for minor lesion somatic mutations.
Therefore, we now performed a comprehensive search for NF1 somatic alterations in melanocytes, keratinocytes, and fibroblasts obtained from NF1 CALMs, allowing identification of LOH, copy-number changes of one to multiple exons, and minor lesion mutations. Three keratinocyte, 11 fibroblast and five melanocyte CALM-derived primary cell cultures of 13 patients with a known germline NF1 mutation were examined, in addition to six melanocyte cultures from neonatal foreskin of healthy control persons.
Patients were diagnosed according to the NIH diagnostic criteria. Skin biopsies from NF1 CALMs were taken after written informed consent, and guided by the institutional ethics committee and the Declaration of Helsinki Principles. Skin biopsies and cell cultures were performed essentially as described in De Schepper et al. (2006) .
For genomic DNA (gDNA) extraction (QiaAmp, Belelux, Spoorstraat, Venlo, The Netherlands) or Gentra Puregene (Qiagen, Venlo, The Netherlands), RNA isolation (Rneasy; Qiagen), and cDNA synthesis (iScript; BioRad) the manufacturer's instructions were followed.
LOH in the NF1 gene region was evaluated by genotyping two telomeric microsatellite markers and four within the NF1 gene as described previously (Wimmer et al., 2006) . Primer sequences can be found in Table 1 . Fragments for all loci were compared between DNA extracted from peripheral blood leukocytes from each patient and the CALM derived cell cultures.
NF1 gene somatic mutation analysis was performed essentially as described in Vandenbroucke et al. (2004) . All mutations found at the cDNA level were confirmed on gDNA. If no somatic hit was detected after sequencing of the entire coding region, multiplex ligation probe assay analysis using the P081/P082 assay (MRC Holland) was performed as described (Wimmer et al., 2006) . In order to determine whether both NF1 mutations detected in melanocyte cultures derived from the CALM of patient NF-008 resided on different alleles, cloning experiments were performed using the pCR2.1-TOPO Vector (Invitrogen, Merelbeke, Belgium).
LOH analysis
LOH analysis could not detect a somatic event in any of the investigated samples. All patients displaying hetero- (Table 2) . Since the six polymorphic markers span the NF1 gene, this analysis excludes loss of the wildtype NF1 allele in NF1-related CALMs. Six normal skin melanocyte cultures obtained from healthy controls and cultured in exactly the same way as the NF1 CALM melanocyte samples were subjected to microsatellite marker and multiplex ligation probe assay analysis. Two NF1 copies were present in all melanocyte cultures and no copynumber changes were detected.
Long-range PCR and direct sequencing of the entire NF1 coding region
The germline NF1 mutation was confirmed to be present in the 11 CALM-derived fibroblast cultures, the three keratinocyte cultures, and five melanocyte cultures. In addition, an additional NF1 mutation was identified in all CALM-derived melanocyte cultures. Three were nonsense mutations: c.2269 A4T (p.K757X), c.4537 C4T (p.R1513X), and c.3721C4T (p.R1241X). One was a splice mutation (c.1721 þ 542A4G), increasing the strength of a cryptic splice donor site in intron 11, that gets used in conjunction with a cryptic intronic splice acceptor site, leading to insertion of 176 bp from intron 11 in the mature transcript. Finally, one culture showed loss of expression of the wild-type NF1 allele No NF1 gene mutations were detected in the six melanocyte cultures obtained from neonatal foreskin from healthy controls using comprehensive mutation analysis, and microsatellite analysis showed presence of two NF1 copies.
The etiopathogenesis of neurofibroma formation in NF1 mouse models was recently ascribed to neurofibromindeficient Schwann cells (NF1 This study wants to address whether a similar mechanism, based on neurofibromin deficiency due to a second hit mutation, is also applicable for the NF1 CALMs. Several researchers have tried to characterize CALMs histologically, but with conflicting results (Kawamura, 1956; Benedict et al., 1968; Johnson and Charneco, 1970; Takahashi, 1976; Frenck and Marazzi, 1984; Ishida and Jimbow, 1987; Grossman et al., 1995) . We recently demonstrated that the melanocyte density is increased in NF1 CALM skin compared with NF1 normal skin and healthy control CALM, and normal skin (De Schepper et al., 2006) .
In line with this study, an NF1 second hit in NF1 CALM melanocytes was found in 5/5 available melanocyte cultures, but not in the keratinocytes or fibroblasts from these café au lait spots. No NF1 mutations were found in the melanocyte cultures from neonatal foreskin from healthy control persons.
This study confirms and extends the findings of a second hit mutation in melanocyte cultures from a segmental and mosaic NF patient (Maertens et al., 2007) . We conclude from our study that there is a statistically significant difference (Po0.05) in the frequency of second hit mutations in CALM melanocytes (5/5) compared with CALM fibroblasts (0/11) (P ¼ 0.000, Fisher's Exact Test), and with CALM keratinocytes (0/ 3) (P ¼ 0.018, Fisher's Exact Test). So far no evidence points to a significant contribution of LOH to CALM formation. Six healthy control normal skin melanocyte cultures, which were analyzed as negative controls did not show any somatic NF1 alterations.
The finding of second hit mutations in NF1 CALM melanocytes improves our understanding of the etiopathogenic mechanisms underlying the formation of this hyperpigmentary disorder, and will boost further research aiming to understand the phenotypes associated with somatic mutations in melanocytes. Messiaen 
